Expansion mutation in C9ORF72 does not influence plasma progranulin levels in frontotemporal dementia

Neurobiology of Aging

Volumn 33, Issue 8, 2012, Pages 1851.e17-1851.e19

  Dols Icardo, Oriol ^a,b   Suárez Calvet, Marc ^a,b   Hernández, Isabel ^c   Amer, Guillermo ^d   Antón Aguirre, Sofía ^a,b   Alcolea, Daniel ^a,b   Fortea, Juan ^a,b   Boada, Mercè ^c   Tárraga, Lluís ^c   Blesa, Rafael ^a,b   Lleó, Alberto ^a,b   Clarimón, Jordi ^a,b  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^b CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED SOBRE ENFERMEDADES NEURODEGENERATIVAS CIBERNED   (Spain)

^c Inst Catala de Neurociencies Apl   (Spain)

^d HOSPITAL UNIVERSITARIO SON ESPASES   (Spain)

Author keywords

Biomarkers; C9ORF72; Frontotemporal dementia; Genetics; Progranulin

Indexed keywords

PROGRANULIN; GRN PROTEIN, HUMAN; LRRK2 PROTEIN, HUMAN; PROTEIN SERINE THREONINE KINASE; SIGNAL PEPTIDE;

ADULT; AGED; ARTICLE; CHROMOSOME 9 OPEN READING FRAME 72 GENE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FRONTOTEMPORAL DEMENTIA; GENE; GENETIC SCREENING; HETEROZYGOTE; HEXANUCLEOTIDE REPEAT; HUMAN; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE REPEAT; PEDIGREE ANALYSIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; BLOOD; GENETIC MARKER; GENETIC PREDISPOSITION; GENETIC VARIABILITY; GENETICS; MIDDLE AGED; MUTATION; PREVALENCE; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; SPAIN;

ADULT; FEMALE; FRONTOTEMPORAL DEMENTIA; GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MIDDLE AGED; MUTATION; POLYMORPHISM, SINGLE NUCLEOTIDE; PREVALENCE; PROTEIN-SERINE-THREONINE KINASES; REPETITIVE SEQUENCES, NUCLEIC ACID; RISK FACTORS; SPAIN;

EID: 84861919479     PISSN: 01974580     EISSN: 15581497     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2012.03.005     Document Type: Article

References (12)

1. Carrasquillo M.M., Nicholson A.M., Finch N., Gibbs J.R., Baker M., Rutherford N.J., Hunter T.A., DeJesus-Hernandez M., Bisceglio G.D., Mackenzie I.R., Singleton A., Cookson M.R., Crook J.E., Dillman A., Hernandez D., Petersen R.C., Graff-Radford N.R., Younkin S.G., Rademakers R. Genome-wide screen identifies rs646776 near sortilin as a regulator of progranulin levels in human plasma. Am. J. Hum. Genet 2010, 87:890-897.
2. Cruts M., Gijselinck I., van der Zee J., Engelborghs S., Wils H., Pirici D., Rademakers R., Vandenberghe R., Dermaut B., Martin J.J., van Duijn C., Peeters K., Sciot R., Santens P., De Pooter T., Mattheijssens M., Van den Broeck M., Cuijt I., Vennekens K., De Deyn P.P., Kumar-Singh S., Van Broeckhoven C. Null mutations in progranulin cause ubiquitin-positive frontotemporal dementia linked to chromosome 17q21. Nature 2006, 442:920-924.
3. DeJesus-Hernandez M., Mackenzie I.R., Boeve B.F., Boxer A.L., Baker M., Rutherford N.J., Nicholson A.M., Finch N.A., Flynn H., Adamson J., Kouri N., Wojtas A., Sengdy P., Hsiung G.Y., Karydas A., Seeley W.W., Josephs K.A., Coppola G., Geschwind D.H., Wszolek Z.K., Feldman H., Knopman D.S., Petersen R.C., Miller B.L., Dickson D.W., Boylan K.B., Graff-Radford N.R., Rademakers R. Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS. Neuron 2011, 72:245-256.
4. Finch N., Carrasquillo M.M., Baker M., Rutherford N.J., Coppola G., Dejesus-Hernandez M., Crook R., Hunter T., Ghidoni R., Benussi L., Crook J., Finger E., Hantanpaa K.J., Karydas A.M., Sengdy P., Gonzalez J., Seeley W.W., Johnson N., Beach T.G., Mesulam M., Forloni G., Kertesz A., Knopman D.S., Uitti R., White C.L., Caselli R., Lippa C., Bigio E.H., Wszolek Z.K., Binetti G., Mackenzie I.R., Miller B.L., Boeve B.F., Younkin S.G., Dickson D.W., Petersen R.C., Graff-Radford N.R., Geschwind D.H., Rademakers R. TMEM106B regulates progranulin levels and the penetrance of FTLD in GRN mutation carriers. Neurology 2011, 76:467-474.
5. Ghidoni R., Benussi L., Glionna M., Franzoni M., Binetti G. Low plasma progranulin levels predict progranulin mutations in frontotemporal lobar degeneration. Neurology 2008, 71:1235-1239.
6. Ghidoni R., Stoppani E., Rossi G., Piccoli E., Albertini V., Paterlini A., Glionna M., Pegoiani E., Agnati L.F., Fenoglio C., Scarpini E., Galimberti D., Morbin M., Tagliavini F., Binetti G., Benussi L. Optimal Plasma Progranulin Cutoff Value for Predicting Null Progranulin Mutations in Neurodegenerative Diseases: A Multicenter Italian Study. Neurodegener. Dis 2012, 9:121-127.
7. Leyton C.E., Villemagne V.L., Savage S., Pike K.E., Ballard K.J., Piguet O., Burrell J.R., Rowe C.C., Hodges J.R. Subtypes of progressive aphasia: application of the International Consensus Criteria and validation using beta-amyloid imaging. Brain 2011, 134:3030-3043.
8. López de Munain A., Alzualde A., Gorostidi A., Otaegui D., Ruiz-Martínez J., Indakoetxea B., Ferrer I., Pérez-Tur J., Sáenz A., Bergareche A., Barandiarán M., Poza J.J., Zabalza R., Ruiz I., Urtasun M., Fernández-Manchola I., Olasagasti B., Espinal J.B., Olaskoaga J., Ruibal M., Moreno F., Carrera N., Martí-Massó J.F. Mutations in progranulin gene: clinical, pathological, and ribonucleic acid expression findings. Biol. Psychiatry 2008, 63:946-952.
9. Mackenzie I.R., Neumann M., Bigio E.H., Cairns N.J., Alafuzoff I., Kril J., Kovacs G.G., Ghetti B., Halliday G., Holm I.E., Ince P.G., Kamphorst W., Revesz T., Rozemuller A.J., Kumar-Singh S., Akiyama H., Baborie A., Spina S., Dickson D.W., Trojanowski J.Q., Mann D.M. Nomenclature and nosology for neuropathologic subtypes of frontotemporal lobar degeneration: an update. Acta. Neuropathol 2010, 119:1-4.
10. Murray M.E., DeJesus-Hernandez M., Rutherford N.J., Baker M., Duara R., Graff-Radford N.R., Wszolek Z.K., Ferman T.J., Josephs K.A., Boylan K.B., Rademakers R., Dickson D.W. Clinical and neuropathologic heterogeneity of c9FTD/ALS associated with hexanucleotide repeat expansion in C9ORF72. Acta. Neuropathol 2011, 122:673-690.
11. Rascovsky K., Hodges J.R., Knopman D., Mendez M.F., Kramer J.H., Neuhaus J., van Swieten J.C., Seelaar H., Dopper E.G., Onyike C.U., Hillis A.E., Josephs K.A., Boeve B.F., Kertesz A., Seeley W.W., Rankin K.P., Johnson J.K., Gorno-Tempini M.L., Rosen H., Prioleau-Latham C.E., Lee A., Kipps C.M., Lillo P., Piguet O., Rohrer J.D., Rossor M.N., Warren J.D., Fox N.C., Galasko D., Salmon D.P., Black S.E., Mesulam M., Weintraub S., Dickerson B.C., Diehl-Schmid J., Pasquier F., Deramecourt V., Lebert F., Pijnenburg Y., Chow T.W., Manes F., Grafman J., Cappa S.F., Freedman M., Grossman M., Miller B.L. Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia. Brain 2011, 134:2456-2477.
12. Renton A.E., Majounie E., Waite A., Simón-Sánchez J., Rollinson S., Gibbs J.R., Schymick J.C., Laaksovirta H., van Swieten J.C., Myllykangas L., Kalimo H., Paetau A., Abramzon Y., Remes A.M., Kaganovich A., Scholz S.W., Duckworth J., Ding J., Harmer D.W., Hernandez D.G., Johnson J.O., Mok K., Ryten M., Trabzuni D., Guerreiro R.J., Orrell R.W., Neal J., Murray A., Pearson J., Jansen I.E., Sondervan D., Seelaar H., Blake D., Young K., Halliwell N., Callister J.B., Toulson G., Richardson A., Gerhard A., Snowden J., Mann D., Neary D., Nalls M.A., Peuralinna T., Jansson L., Isoviita V.M., Kaivorinne A.L., Hölttä-Vuori M., Ikonen E., Sulkava R., Benatar M., Wuu J., Chiò A., Restagno G., Borghero G., Sabatelli M., Heckerman D., Rogaeva E., Zinman L., Rothstein J.D., Sendtner M., Drepper C., Eichler E.E., Alkan C., Abdullaev Z., Pack S.D., Dutra A., Pak E., Hardy J., Singleton A., Williams N.M., Heutink P., Pickering-Brown S., Morris H.R., Tienari P.J., Traynor B.J. A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD. Neuron 2011, 72:257-268. ITALSGEN Consortium.